Evolent Health (EVH) vs SOPHiA GENETICS SA (SOPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SOPHiA GENETICS SA (SOPH) has outperformed Evolent Health (EVH) over the past year, gaining 71.9% versus a loss of 49.0%. Over five years, SOPH leads with a -55.6% price change compared with -86.2% for EVH. SOPHiA GENETICS SA is the larger company by market cap ($608.7 million vs $468.1 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVH | SOPH |
|---|---|---|
| Share price | $4.14 | $7.15 |
| Market cap | $468.07M | $608.66M |
| 1-day change | +7.81% | -3.12% |
| YTD return | +3.50% | +53.10% |
| 1-year return | -49.01% | +71.88% |
| 5-year return | -86.17% | -55.59% |
| Forward P/E | 10.25 | — |
| EPS (TTM) | $-4.49 | $-1.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.33 | $8.98 |
| 52-week low | $2.10 | $3.75 |
| Distance from 52-week high | -50.30% | -20.38% |
| Analyst consensus | buy | none |
| Avg. price target upside | +38.89% | +36.36% |
| Average volume | 2.99M | 547.82K |
| Shares outstanding | 113.06M | 85.13M |
| Employees | 4,200 | 415 |
| Sector | Consumer Discretionary | Technology |
| Industry | Other Consumer Services | EDP Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SOPH has outperformed EVH by 120.9 percentage points over the past year.
- The two companies sit in different sectors: Evolent Health in Consumer Discretionary and SOPHiA GENETICS SA in Technology.
About Evolent Health
EVH stock →Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management.
Consumer Discretionary · Other Consumer Services · 4,200 employees
About SOPHiA GENETICS SA
SOPH stock →SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Technology · EDP Services · 415 employees
EVH vs SOPH FAQ
Which is bigger, Evolent Health or SOPHiA GENETICS SA?
SOPHiA GENETICS SA (SOPH) is larger, with a market capitalization of $608.66M compared with $468.07M for Evolent Health (EVH).
Which stock has performed better over the past year, EVH or SOPH?
SOPH returned +71.88% over the past 12 months, compared with -49.01% for EVH (price return, excluding dividends). Past performance does not predict future results.
Are Evolent Health and SOPHiA GENETICS SA in the same industry?
No. Evolent Health is in the Consumer Discretionary sector, while SOPHiA GENETICS SA is in Technology.